Artículos de opinión
Evaluación económica de medicamentos: experiencias y vías de avance
Economic drug evaluation: experiences and pathways to progress
José Antonio Sacristána,
, Tatiana Dillaa, José Luis Pintob, Fernando Antoñanzasc
Corresponding author
sacristan-jose@lilly.com
Correspondencia: José Antonio Sacristán. Departamento de Investigación Clínica, Lilly. Avda. de la Industria, 30. 28108 Alcobendas. Madrid. España.
Correspondencia: José Antonio Sacristán. Departamento de Investigación Clínica, Lilly. Avda. de la Industria, 30. 28108 Alcobendas. Madrid. España.
Read
663
Timeswas read the article
233
Total PDF
430
Total HTML
Article information
ISSN: 02139111Original language: Spanish
DOI:10.1157/13125358
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 29 | 16 | 45 |
| 2024 April | 40 | 16 | 56 |
| 2024 March | 44 | 19 | 63 |
| 2024 February | 40 | 46 | 86 |
| 2024 January | 43 | 19 | 62 |
| 2023 December | 25 | 11 | 36 |
| 2023 November | 31 | 18 | 49 |
| 2023 October | 33 | 14 | 47 |
| 2023 September | 31 | 11 | 42 |
| 2023 August | 30 | 18 | 48 |
| 2023 July | 35 | 21 | 56 |
| 2023 June | 33 | 13 | 46 |
| 2023 May | 16 | 11 | 27 |
Show all
